Literature DB >> 15923241

The endothelin system and its role in pulmonary arterial hypertension (PAH).

J Pepke-Zaba, N W Morrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15923241      PMCID： PMC1747432          DOI： 10.1136/thx.2004.031724

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

1.  Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.

Authors:  Jahidur Rashid; Ahmad Alobaida; Taslim A Al-Hilal; Samia Hammouda; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2018-04-30       Impact factor: 9.776

2.  Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Sanjiv Kumar; Shruti Sharma; Saurabh Aggarwal; Frank Schneider; Danny Jonigk; Stephen M Black; Stevan P Tofovic
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

3.  Reversible pulmonary hypertension related to thalidomide treatment for multiple myeloma.

Authors:  Antonio Villa; Anna Alice Mazzola; Stefano Ghio; Elena Martinoli; Pietro Marino
Journal:  Case Rep Oncol       Date:  2011-09-28

4.  Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction.

Authors:  Tatyana Novoyatleva; Yves Schymura; Wiebke Janssen; Frederic Strobl; Jakub M Swiercz; Chinmoy Patra; Guido Posern; Astrid Wietelmann; Timothy S Zheng; Ralph T Schermuly; Felix B Engel
Journal:  Basic Res Cardiol       Date:  2013-01-17       Impact factor: 17.165

5.  Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.

Authors:  Peter M George; Morven E Cunningham; Neil Galloway-Phillipps; Rekha Badiger; William Alazawi; Graham R Foster; Jane A Mitchell
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

6.  EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension.

Authors:  Mei Mei; Guoqiang Cheng; Bijun Sun; Lin Yang; Huijun Wang; Jinqiao Sun; Wenhao Zhou
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

7.  A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.

Authors:  Mariann Bombicz; Daniel Priksz; Balazs Varga; Andrea Kurucz; Attila Kertész; Akos Takacs; Aniko Posa; Rita Kiss; Zoltan Szilvassy; Bela Juhasz
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.